Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 17/20 | 0.67 |
| ▸ | ADRB2 | P07550 | 12/20 | 0.67 |
| ▸ | ADRB1 | P08588 | 12/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7248956 | 0.99 | ADRB3 (0.65) | ADRB3ADRB2ADRB1MEN1ALDH1A1 | |
| SCHEMBL7245557 | 0.86 | ADRB3 (0.56) | ADRB3ADRB2ADRB1MEN1ALDH1A1 | |
| SCHEMBL6480806 | 0.81 | MEN1 (0.55) | ADRB3ADRB2ADRB1MEN1ALDH1A1 | |
| SCHEMBL9683296 | 0.81 | ADRB3 (0.86) | ADRB3ADRB2ADRB1 | |
| SCHEMBL9330198 | 0.81 | ADRB3 (0.86) | ADRB3ADRB2ADRB1 | |
| Hydrochloric Acid SCHEMBL11231256 | 0.81 | ADRB3 (0.86) | ADRB3ADRB2ADRB1MEN1ALDH1A1 | |
| SCHEMBL7250507 | 0.80 | ADRB3 (0.61) | ADRB3ADRB2ADRB1PTGS1SLC6A2 | |
| SCHEMBL9685312 | 0.79 | ADRB3 (0.87) | ADRB3ADRB2ADRB1MEN1ALDH1A1 | |
| SCHEMBL9684040 | 0.79 | ADRB3 (0.87) | ADRB3ADRB2ADRB1MEN1ALDH1A1 | |
| SCHEMBL9684048 | 0.79 | ADRB3 (0.87) | ADRB3ADRB2ADRB1MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030073846-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073846-A1 | Aminoalcohol derivatives | XDH, ADH1A, ADRB1 | ADRB3 20/4885ADRB2 4/4885ADRB1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.